A study of clinical services provided by pharmacists in Ontario hospitals

Canadian Journal of Hospital Pharmacy

Volumn 49, Issue 1 SUPPL., 1996, Pages

  Ogle, Barbara G ^a   McLean, William M ^b   Poston, Jeffrey W ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Pharmaceutical Research Outcomes Unit

^c Canadian Pharmaceutical Association

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; DRUG COST; DRUG MONITORING; DRUG THERAPY; HEALTH SERVICE; HOSPITAL PHARMACY; PATIENT CARE; PHARMACEUTICAL CARE; QUALITY CONTROL; REVIEW;

EID: 0029996375     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anon. Directions for clinical practice. Proceedings of an invitational conference conducted by the ASHP Research and Education Foundation and the American Society of Hospital Pharmacists. Am J Hosp Pharm 1985;42:1287-342.
2. Ontario Hospital Association and Ontario Branch, Canadian Society of Hospital Pharmacists, Toronto, Ontario, 1989. Results of a survey of hospital pharmacy services. Third submission to the Pharmaceutical Inquiry of Ontario.
3. Avorn J, Soumerai SB. Improving drug therapy decisions through educational outreach. N Engl J Med 1983;308:1457-63.
4. Jewesson PJ, Ho R, Jang Q. Auditing antibiotic use in a teaching hospital. Focus on cefoxitin. Can Med Assoc J 1983;128:1075-8.
5. National Health Expenditures in Canada from 1975-1987, Statistics Canada.
6. Gorecki PK. Controlling drug expenditure in Canada - the Ontario experience. Economic Council of Canada and Ontario Ministry of Health. Ministry of Supply and Services Canada. Ottawa, Ontario 1992.
7. Davern PF, Kubica AJ. Controlling drug costs: administrative and clinical strategies. Top Hosp Pharm Manage 1984;Feb:49-59.
8. Gagnon D. Working in partnerships: Drug review for the future. Ministry of Supply and Services, Ottawa, Ontario, 1992.
9. Canadian Society of Hospital Pharmacists Statement on Pharmaceutical Care. Can J Hosp Pharm 1992;45:256-7.
10. Willet MS, Bertch KE, Rich DS, et al. Prospectus on the value of clinical pharmacy services. A position statement of the American College of Clinical Pharmacy. Pharmacotherapy 1989;9:45-56.
11. Hatoum HT, Cotizone C, Hutchison RA, et al. An eleven year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
12. McLeod DC. Contribution of clinical pharmacists to patient care. Am J Hosp Pharm 1976;33:904-11.
13. Tsuyuki RT, Nakagawa RS. The effect of pharmacy intervention on aminoglycoside costs. Can J Hosp Pharm 1987;40:51-6.
14. Anon. Pharmacy: The Report of a Committee of Inquiry. The Nuffield Foundation, London, England 1986;1:151.
15. The Role of the Pharmacist in the Health Care System. World Health Organization, Geneva, Switzerland, 1990.
16. Bjornson DC, Hiner WO Jr, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
17. Zellmer WA. Can pharmacists prevent drug-induced illness in hospitals? Am J Hosp Pharm 1981;38:637.
18. Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges and length of stay. Am J Hosp Pharm 1991;48:1457-62.
19. Hatoum HT, Hutchinson RA, Whitte KW, et al. Evaluation of the contributions of clinical pharmacists: Inpatient care and cost reductions. Drug Intell Clin Pharm 1988;22:252-9.
20. Report of the Pharmaceutical Inquiry of Ontario (The Lowy Commission), Toronto, Ontario 1990.
21. Submission to the British Columbia Royal Commission on Health Care. British Columbia Branch, Canadian Society of Hospital Pharmacists, Vancouver, B.C. 1991.
22. Torok N, Brown G. The economic impact of clinical pharmacists' unsolicited recommendations. Hosp Pharm 1992;27:1052-60.
23. Brown G. Assessing the clinical impact of pharmacists' interventions. Am J Hosp Pharm 1991;48:2644-7.
24. Torchinsky A, Landry D. An analysis of pharmacist interventions. Can J Hosp Pharm 1991;44:245-8,270.
25. Bayliff CD, Einarson TR. Physician assessment of pharmacist interventions - a method for estimating cost avoidance and determining quality assurance. Can J Hosp Pharm 1990;4:167-71,195.
26. Strong DK, Tsang GWY. Focus and impact of pharmacists' interventions. Can J Hosp Pharm 1993;46:101-8.
27. Einarson TR, Mann JL. Survey of pharmacotherapy monitoring in Canadian acute care hospitals. Can J Hosp Pharm 1989;42:229-34.
28. Phillips JO, Strand LM, Chesteen SA, et al. Functional and structural prerequisites for clinical pharmacy services. Am J Hosp Pharm 1987;44:1598-605.
29. Greco R, Mann JL, Graham K. Therapeutic interventions. Dimensions 1990 (Nov):23-5.
30. Clinical Pharmacy Activities Committee. A White Paper on the Establishment and Elaboration of Clinical Pharmacy Services. Canadian Society of Hospital Pharmacists, Ottawa, Ontario, 1990.
31. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
32. Brown GR, Miyata M. Improving pharmacy input in patient care through reorganization of clinical functions. Can J Hosp Pharm 1990;43:131-3.
33. Bayliff CD, Bombassaro AM. Assessment of interventions performed during clinical and distribution time [abstract]. Presented at the Canadian Society of Hospital Pharmacists Professional Practice Conference, Toronto, Ontario, February, 1992.
34. Norusis MJ. SPSS/PC+ Base System User Guide, Version 5.0. SPSS Inc., Chicago, IL, 1992, p. 170.
35. Canada Hospital Pharmacy Annual Report. Eli Lilly Canada Inc. Don Mills, Ontario 1992/93.
36. Hubbard CN, Alder G. Interventions during prescription checking on ward rounds. Pharm J 1992;248:162-3.
37. Ho L, Brown GR, Millin B. Characterization of errors detected during central order review. Can J Hosp Pharm 1992;45:193-7.
38. Bertch KE, Hatoum HT, Willett MS, et al. Cost justification of clinical pharmacy services on a general surgery team: focus on diagnosis-related group cases. Drug Intell Clin Pharm 1988;22:906-11.
39. Briceland LL, Kane MP, Hamilton RA. Evaluation of patient-care interventions by Pharm.D. clerkship students. Am J Hosp Pharm 1992;49:1130-2.
40. Masters M, Krstenasky PM. Positive effect of pharmaceutical care interventions in an internal medicine in-patient setting. Ann Pharmacother 1992;26:264.
41. Haslett TM, Kay BG, Weissfellner H. Documenting concurrent clinical pharmacy interventions. Hosp Pharm 1990;25:351-5, 359.
42. Treleaven S, Einarson TR. Cost containment measures in hospital pharmacy: A bibliography. Can J Hosp Pharm 1990;1:17-25.
43. Catania HF, Catania PN. Using clinical interventions to cost-justify additional pharmacy staff. Hosp Pharm 1988;23:544-8.
44. Perkins LD, Mason NA. Justifying additional pharmacy staff in an era of cost reductions. Am J Hosp Pharm 1984;41:2033-6.
45. Hoffmann RP, Sueska KJ. Maintaining clinical pharmacy services during cost containment. Hosp Pharm 1985;20:15-22.
46. Clapham CE, Hepler CD, Reinders TP et al. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988;45:2329-40.
47. Condron JH, Mann JL. Drug utilization and therapeutic intervention programs: pharmacy services that pay for themselves. Can J Hosp Pharm 1994;47:203-8.
48. Harrigan ML. Quality of care: Issues and challenges in the 90s. A literature review. Canadian Medical Association, Ottawa, Ontario 1992.